2009
DOI: 10.1590/s1413-86702009000500014
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated tuberculosis presenting as mesenteric and cerebral abscess in HIV infection: case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…[10] TB presenting as isolated mesenteric mass is rare, and only a few anecdotal case reports are available in the current literature. [11121314] All these cases on histopathology showed conglomerate necrotic mesenteric lymph nodal masses with granulomatous inflammation.…”
Section: Discussionmentioning
confidence: 98%
“…[10] TB presenting as isolated mesenteric mass is rare, and only a few anecdotal case reports are available in the current literature. [11121314] All these cases on histopathology showed conglomerate necrotic mesenteric lymph nodal masses with granulomatous inflammation.…”
Section: Discussionmentioning
confidence: 98%
“…6,8 Disseminated tuberculosis is treated with standard antituberculosis drugs (intensive phase, two months including isoniazide (INH), rifampicin, streptomycin, and pyrazinamide; intermittent phase, seven months including INH and rifampicin) are required. [3][4][5][6]10 This can be challenging for some physicians in giving antituberculosis drugs to people with liver disease, hence liver tuberculosis.…”
Section: Discussionmentioning
confidence: 99%
“…[ 72 ] Although there is no consensus regarding the optimum duration of treatment in patients with disseminated TB,[ 47 ] early initiation of therapy is associated with a significant improvement in outcomes. [ 1 73 74 ]…”
Section: Treatment Outcome and Complicationsmentioning
confidence: 99%
“…The treatment is then continued with rifampicin and isoniazid for a further 4 months, with the possibility of being extended to 7 months in some cases. [ 72 73 ] Response to first-line anti-TB drugs is good as evidenced by many reports. [ 1 47 ] For multidrug resistance TB, treatment with a minimum of 1 susceptible injectable and at least 3 additional susceptible drugs, to prevent the development of additional resistance, is required.…”
Section: Treatment Outcome and Complicationsmentioning
confidence: 99%